Halozyme Therapeutics, Inc.

Rockefeller Capital Management L.P. HALO

Report date

12/31/2025

Quarter

2025 Q4

Filed

3/16/2026

Shares

5,586

Value ($000)

376

Weight

0.0%

2019 Q4 - 2025 Q4 (22 filings)

Shares History

History scope: non-option holdings only (PUT/CALL rows excluded).

All 13F Holders	Filing date	Value ($000s)	% of Holdings	Shares	Reporting period
2025 Q4	3/16/2026	376	0.0%	5,586	12/31/2025
2025 Q3	11/14/2025	340	0.0%	4,640	9/30/2025
2024 Q3	11/14/2024	3,780	0.0%	66,038	9/30/2024
2024 Q2	8/12/2024	3,729	0.0%	71,225	6/30/2024
2024 Q1	5/14/2024	3,037	0.0%	74,655	3/31/2024
2023 Q4	2/14/2024	2,617	0.0%	70,809	12/31/2023
2023 Q3	11/14/2023	2,687	0.0%	70,342	9/30/2023
2023 Q2	8/14/2023	2,039	0.0%	56,530	6/30/2023
2023 Q1	5/16/2023	1,393	0.0%	36,482	3/31/2023
2022 Q4	3/6/2023	1,871	0.0%	32,883	12/31/2022
2022 Q3	11/2/2022	395	0.0%	10,014	9/30/2022
2022 Q2	8/12/2022	467	0.0%	10,627	6/30/2022
2022 Q1	5/13/2022	331	0.0%	8,307	3/31/2022
2021 Q4	2/14/2022	343	0.0%	8,549	12/31/2021
2021 Q3	11/12/2021	338	0.0%	8,313	9/30/2021
2021 Q2	8/10/2021	26	0.0%	573	6/30/2021
2021 Q1	5/11/2021	22	0.0%	533	3/31/2021
2020 Q4	2/12/2021	21	0.0%	500	12/31/2020
2020 Q3	11/13/2020	13	0.0%	500	9/30/2020
2020 Q2	8/12/2020	163	0.0%	6,088	6/30/2020
2020 Q1	5/12/2020	131	0.0%	7,305	3/31/2020
2019 Q4	2/7/2020	9	0.0%	500	12/31/2019